Trial Profile
Exploratory study to determine S-588410-induced tumor infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2020
Price :
$35
*
At a glance
- Drugs Asudemotide (Primary) ; Montanide ISA-51
- Indications Adenocarcinoma; Oesophageal cancer; Squamous cell cancer
- Focus Pharmacodynamics
- Sponsors Shionogi
- 01 Nov 2020 Results published in the Cancer Immunology Immunotherapy
- 12 Jun 2020 According to an OncoTherapy Science media release, results from this study has been published in Cancer Immunology, Immunotherapy.
- 12 Jun 2020 Results presented in an OncoTherapy Science media release.